LIONEX  is a German biotech company active in the fields of biomedicine and human health with special emphasis on TUBERCULOSIS (TB). Our focus is on research and In-Vitro-Diagnostic (IVD) product development for infectious diseases and cancer. LIONEX has recently launched a new IGRA (Interferon Gamma Release Assay) diagnostic test  called LIOFeron®TB/LTBI for LTBI (Latent Tuberculosis Infection). It may also react positive in TB patients also but, as for other similar IGRA tests on the market, it cannot differentiate between LTBI and active TB.

LIONEX is a leading manufacturer of highly purified, endotoxin free, mycobacterial antigens for research on tuberculosis and other mycobacterial diseases.

LIONEX is the licensed, exclusive manufacturer and distributor of a widely known family of endotoxin removal resin under the brand name EndoTrap®. EndoGrade®Ovalbumin is another useful product for research on vaccine development.

Bovine tuberculosis tests are also available for research.